GSC
Basic information
Region (hg38): 14:94768223-94770113
Links
Phenotypes
GenCC
Source:
- short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome (Supportive), mode of inheritance: AR
- short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Short Stature, Auditory-Canal Atresia, Mandibular Hypoplasia, and Skeletal Abnormalities (SAMS) | AR | Audiologic/Otolaryngologic | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic; Craniofacial; Genitourinary; Musculoskeletal | 9475592; 24290375 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GSC gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 20 | 27 | ||||
missense | 38 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 5 | |||||
Total | 0 | 0 | 40 | 23 | 11 |
Variants in GSC
This is a list of pathogenic ClinVar variants found in the GSC region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-94768521-T-C | Likely benign (Jan 13, 2023) | |||
14-94768550-TCGA-T | Likely benign (Jan 08, 2024) | |||
14-94768565-T-C | not specified | Uncertain significance (Mar 15, 2024) | ||
14-94768580-C-A | not specified | Uncertain significance (Feb 22, 2023) | ||
14-94768614-C-A | Likely benign (Oct 13, 2023) | |||
14-94768772-C-A | Benign (Jun 20, 2021) | |||
14-94768949-G-A | Likely benign (Dec 06, 2022) | |||
14-94768950-G-A | Likely benign (Dec 26, 2023) | |||
14-94768951-C-A | Likely benign (Sep 27, 2022) | |||
14-94768951-C-T | Likely benign (Jun 22, 2021) | |||
14-94768967-C-G | Uncertain significance (Oct 25, 2022) | |||
14-94768975-G-T | not specified | Uncertain significance (Aug 27, 2024) | ||
14-94768983-A-G | Uncertain significance (Sep 23, 2022) | |||
14-94768997-CT-GG | Uncertain significance (Nov 28, 2022) | |||
14-94769002-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
14-94769007-G-A | Uncertain significance (Mar 28, 2022) | |||
14-94769009-G-A | Uncertain significance (Dec 22, 2021) | |||
14-94769018-C-T | Likely benign (Oct 25, 2021) | |||
14-94769021-G-A | Benign (Jan 21, 2024) | |||
14-94769026-T-G | Uncertain significance (Aug 16, 2022) | |||
14-94769034-T-C | not specified | Uncertain significance (Dec 08, 2023) | ||
14-94769081-G-A | Likely benign (May 16, 2022) | |||
14-94769084-G-A | Likely benign (Nov 13, 2023) | |||
14-94769111-C-A | not specified | Uncertain significance (Dec 07, 2021) | ||
14-94769111-C-T | Likely benign (Oct 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GSC | protein_coding | protein_coding | ENST00000238558 | 3 | 2010 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0139 | 0.878 | 125741 | 0 | 5 | 125746 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.917 | 82 | 109 | 0.753 | 0.00000546 | 1600 |
Missense in Polyphen | 36 | 48.463 | 0.74283 | 642 | ||
Synonymous | -1.04 | 60 | 50.6 | 1.19 | 0.00000267 | 523 |
Loss of Function | 1.33 | 4 | 8.10 | 0.494 | 3.54e-7 | 107 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000464 | 0.0000462 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulates chordin (CHRD). May play a role in spatial programing within discrete embryonic fields or lineage compartments during organogenesis. In concert with NKX3-2, plays a role in defining the structural components of the middle ear; required for the development of the entire tympanic ring (By similarity). Probably involved in the regulatory networks that define neural crest cell fate specification and determine mesoderm cell lineages in mammals. {ECO:0000250, ECO:0000269|PubMed:24290375}.;
- Disease
- DISEASE: Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities (SAMS) [MIM:602471]: An autosomal recessive developmental disorder with features of a first and second branchial arch syndrome, and with unique rhizomelic skeletal anomalies. Craniofacial abnormalities can lead to conductive hearing loss, respiratory insufficiency, and feeding difficulties. Skeletal features include bilateral humeral hypoplasia, humeroscapular synostosis, pelvic abnormalities, and proximal defects of the femora. Affected individuals may also have some features of a neurocristopathy or abnormal mesoderm development, such as urogenital anomalies, that are distinct from other branchial arch syndromes. {ECO:0000269|PubMed:24290375}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation;Developmental Biology;POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation;Transcriptional regulation of pluripotent stem cells;Regulation of retinoblastoma protein;Regulation of nuclear SMAD2/3 signaling
(Consensus)
Recessive Scores
- pRec
- 0.219
Haploinsufficiency Scores
- pHI
- 0.204
- hipred
- Y
- hipred_score
- 0.766
- ghis
- 0.574
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.911
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gsc
- Phenotype
- skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; vision/eye phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); taste/olfaction phenotype;
Zebrafish Information Network
- Gene name
- gsc
- Affected structure
- head
- Phenotype tag
- abnormal
- Phenotype quality
- truncated
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;gastrulation;neural crest cell fate specification;dorsal/ventral neural tube patterning;signal transduction involved in regulation of gene expression;negative regulation of Wnt signaling pathway;forebrain development;middle ear morphogenesis;muscle organ morphogenesis;embryonic skeletal system morphogenesis
- Cellular component
- nucleus;transcription factor complex;nuclear body
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II transcription factor binding;RNA polymerase II repressing transcription factor binding;DNA-binding transcription repressor activity, RNA polymerase II-specific